Clinical Trial Update: A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update to evaluate the safety of DWRX5003 and its relative bioavailability to DWC202502 and DWC202503 in healthy adult volunteers; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• DWC202502
• DWC202503
• DWRX5003

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Obesity & Overweight, Type 2 Diabetes | Phase 1 | Status: NOT_YET_RECRUITING